The findings of this cohort study support prior, primarily cross-sectional data, suggesting that individuals with dual LRRK2/GBA variations do not have a worse PD clinical course than individuals with GBA PD or LRRK2 PD alone. The gene discussed is LRRK2; the disease is Parkinson disease.